Skip to main navigation
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Search
Close
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Report
Sep 18, 2019
| Erica Klinger
Report: 2019 Generic Drug & Biosimilars Access & Savings in the U.S.
Report
Sep 9, 2019
| Craig Burton
White Paper Part 2: Failure to Launch: Barriers to Biosimilar Market Adoption
Video
Sep 9, 2019
| Erica Klinger
AAM's Karin Hessler Provides an Inside Look at the GRx+Biosims 2019 Legal Track
Blog
Aug 26, 2019
| Erica Klinger
Giving, Volunteering and More: How Our Members Show They Care
Blog
Jul 30, 2019
| Ashlie Van Meter
A Generic Summer Savings Tour: How Did Your State Do?
Blog
Jul 29, 2019
| Maddy Murphy
Prescription Drug Safety on Campus
Press Release
Jul 23, 2019
| Rachel Schwartz
AAM Applauds Senate Finance’s Meaningful Effort to Reduce Drug Prices for America’s Patients
Video
Jul 19, 2019
| Erica Klinger
AAM's Ashlee Koonce Shares New Exhibitor Opportunities at GRx+Biosims 2019
Video
Jul 19, 2019
| Erica Klinger
AAM's Christine Simmon Talks About Biosimilar Programming at GRx+Biosims 2019
Blog
Jul 11, 2019
| Jonathan Kimball
The House Has Spoken – It’s Time to Fix USMCA’s Pharmaceutical Provisions
Press Release
Jul 2, 2019
| Rachel Schwartz
National Survey Finds Significant Voter Opposition to Patent Settlement Legislation
Press Release
Jun 26, 2019
| Rachel Schwartz
AAM Applauds Sens. Cornyn and Blumenthal’s Efforts to Accelerate Access to More Affordable Biosimilar Medicines
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2025
GRx+Biosims 2024
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action